ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yasunori Watanabe
Katsuo Fuse
Yoshihiro Naruse
Shin Yamamoto
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, Y.
Right arrow Articles by Shibata, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, Y.
Right arrow Articles by Shibata, Y.

Ann Thorac Surg 1992;54:479-484
© 1992 The Society of Thoracic Surgeons

Articles

Subcutaneous use of erythropoietin in heart surgery

Yasunori Watanabe, MD*, Katsuo Fuse, MD, Yoshihiro Naruse, MD, Toshiya Kobayashi, MD, Shin Yamamoto, MD, Hiroaki Konishi, MD, Taikoh Horii, MD, Yoichi Shibata, MD

Divisions of Cardiovascular Surgery and Immunohematology, Toranomon Hospital, Tokyo, Japan

* Address reprint requests to Dr Watanabe, Department of Cardiovascular Surgery, Hitachi General Hospital, 2-1-1, Johnan-cho, Hitachi-shi, Ibaragi 317, Japan.

The effect of subcutaneous administration of recombinant human erythropoietin (rHuEPO) in ameliorating anemia resulting from autologous blood donation was compared with intravenous administration of rHuEPO. Forty patients undergoing coronary artery bypass procedures were divided into three groups. Group I (12 patients) received intravenous administration of rHuEPO (100 U · kg–1 · day–1) and intravenous iron preparations for 14 days before operation; group II (14 patients) had subcutaneous administration of rHuEPO (600 U/kg) on preoperative days 14 and 7 and oral iron preparations for 14 days; and group III (14 patients) received oral iron preparations alone and served as the controls. Each patient predonated 800 mL of blood in the 2 weeks before operation. The reticulocyte count increased significantly in groups I and II (p < 0.01), but little in group III. The hemoglobin level just before operation was higher in groups I (p < 0.01) and II (p < 0.05) compared with group III. Four patients (29%) in group III required homologous blood transfusion versus none in groups I and II (p < 0.05). Subcutaneous administration of rHuEPO once a week was as effective as daily intravenous administration. Preoperative autologous blood donation can be performed over a short period on an outpatient basis with subcutaneous administration of rHuEPO.




This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., December 6, 2011; 58(24): e123 - e210.
[Full Text] [PDF]

Home page
 CirculationHome page
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation, December 6, 2011; 124(23): e652 - e735.
[Full Text] [PDF]

Home page
 Card Surg AdultHome page
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom
Transfusion Therapy and Blood Conservation
Card. Surg. Adult, January 1, 2008; 3(2008): 415 - 430.
[Full Text]

Home page
 Card Surg AdultHome page
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom
Transfusion Therapy and Blood Conservation
Card. Surg. Adult, January 1, 2003; 2(2003): 389 - 400.
[Full Text]

Home page
 Br J AnaesthHome page
V. Sonzogni, G. Crupi, R. Poma, F. Annechino, F. Ferri, P. Filisetti, and P. Bellavita
Erythropoietin therapy and preoperative autologous blood donation in children undergoing open heart surgery
Br. J. Anaesth., September 1, 2001; 87(3): 429 - 434.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. Kiyama, N. Ohshima, T. Imazeki, and T. Yamada
Autologous blood donation with recombinant human erythropoietin in anemic patients
Ann. Thorac. Surg., November 1, 1999; 68(5): 1652 - 1656.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.